AI assistant
Sending…
PTC THERAPEUTICS, INC. — Director's Dealing 2013
Jun 19, 2013
31046_dirs_2013-06-19_16a4744d-4477-44ff-82fe-737f6efe0887.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2013-06-19
Reporting Person: CREDIT SUISSE AG/ (10% Owner)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Series Four Senior Preferred Stock | $ | Common Stock (276853) | Indirect | ||
| Series Five Junior Preferred Stock | $ | Common Stock (1980029) | Indirect |
Footnotes
F1: See Footnote 1 in Exhibit 99.1.
F2: See Footnote 1 in Exhibit 99.1.
F3: See Footnote 1 in Exhibit 99.1.
F4: See Footnote 1 in Exhibit 99.1.
F5: See Footnote 1 in Exhibit 99.1.
More from PTC THERAPEUTICS, INC.
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
Apr 28
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Regulatory Filings
2026
Mar 25
Director's Dealing
2026
Feb 23
Director's Dealing
2026
Feb 20
Director's Dealing
2026
Feb 20
Director's Dealing
2026
Feb 20